Norwegian version of this page

PharmacoEpidemiology and Drug Safety (PharmaSafe)

Medications are an essential aspect of health care. The PharmacoEpidemiology & Drug Safety (PharmaSafe) research group covers a multitude of different research activities related to the safety and optimal use of medications, on both the individual and societal level. We are a multidisciplinary team of researchers, with expertise in a wide range of topics, including pharmacoepidemiology and drug safety, pharmaco(epi)genetics, biostatistics, health economics, and pharmacotherapy. 

Using epidemiological methods, we address questions of drug safety that are challenging to study in randomized controlled trials (RCTs). Our work includes monitoring of drug utilization in pregnancy, examination of perceptions toward medications, methodology and health economic research, and analysis of medication safety on patient outcomes, including genetic and epigenetic contributions.


  • Image may contain: Person, Forehead, Hair, Cheek, Smile. PharmaSafe guest lecture and iAPOGEE seminar June 22, 2022 9:56 PM

    Helga Gardarsdottir, PhD, associate professor at Utrecht Center For Pharmaceutical Policy and Regulation, will give a lecture in Gydas vei 8, Auditorium 1, June 23, 14.00-15.00. The title of the lecture is "Real World Evidence for regulatory and clinical decision making". Please see the poster below.

  • Image may contain: Smile, Lip, Jaw, Sleeve, Happy. PharmaSafe Guest Lecture and iAPOGEE Seminar June 9, 2022 10:39 AM

    Andrea Margulis, MD, ScD, ScM, Director of Epidemiology, RTI Health Solutions, will give a lecture in Gydas vei 8, auditorium 1, 15.30-16.30, June 9, 2022. The title of the lecture is "Perinatal pharmacoepidemiology: a literature review on completeness of reporting". Please see the poster below.

  • Image may contain: Font, Material property, Screenshot, Parallel, Magenta. New article in JAMA Network Open! June 7, 2022 2:18 PM

    PharmaSafe researchers set out to answer the question "Is prenatal exposure to triptans associated with an increased risk of attention-deficit/hyperactivity disorder (ADHD) in offspring?".

  • Image may contain: Smile, Sleeve, Eyelash, Gesture, Throat. Disputation: Gerd Marie Eskerud Harris June 7, 2022 1:59 PM

    PharmaSafe doctoral candidate Gerd Marie Eskerud Harris defends her thesis "Migraine pharmacotherapy during pregnancy: Utilization patterns and associations with child neurodevelopment" for the degree of Philosophiae Doctor.

  • Image may contain: Person, Clothing, Hair, Smile, Lip. Marion Taine joins PharmaSafe! Mar. 20, 2022 9:08 PM

    Marion Taine is a researcher in epidemiology and a paediatrician. She joins PharmaSafe to contribute to the IMI concePTION project assessing migraine drug utilisation during pregnancy. We wish her a warm welcome! Below, Marion presents herself.

Published Oct. 21, 2013 12:16 PM - Last modified June 9, 2022 6:54 PM